Survival Outcomes of Lung Cancer

NCT03647098 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2025-02-14

No results posted yet for this study

Summary

This is a prospective study to analyze the survival outcomes of different groups about lung cancer patients.

Conditions

Interventions

DRUG

Treatment

Treatment decisions guided by molecular profiling and clinical judgment of principal investigators

Sponsors & Collaborators

  • Hunan Province Tumor Hospital

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2028-12-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03647098 on ClinicalTrials.gov